Industry News
Pharmaceutical Industry News
FDA reprimands Amgen for ‘misleading’ Neulasta claims in banner ads aimed at doctors
FDA reprimands Amgen for 'misleading’ Neulasta claims in banner ads aimed at doctors bbulik Thu, 07/15/2021 - 10:30
After 10,000% price hike, pharma companies face $350M-plus fine in U.K.
After 10,000% price hike, pharma companies face $350M-plus fine in U.K. esagonowsky Thu, 07/15/2021 - 09:47
Johnson & Johnson yanks Neutrogena and Aveeno spray sunscreens on carcinogen fears
Johnson & Johnson yanks Neutrogena and Aveeno spray sunscreens on carcinogen fears fkansteiner Thu, 07/15/2021 - 09:23
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients
The rejection of the new Alzheimer’s drug by the two major medical centers is one of the starkest signs of concern over its approval by the F.D.A.
The way it grows: CMI Media Group and Compas tap new leadership to build on gains
The way it grows: CMI Media Group and Compas tap new leadership to build on gains bbulik Wed, 07/14/2021 - 23:01
Johnson & Johnson Recalls Sunscreen Because of Benzene Traces
The company said it had determined that daily exposure to five Neutrogena and Aveeno sprays would not cause adverse health effects, but recalled the products out of an abundance of caution.
Sprout’s female libido drug Addyi back in FDA’s crosshairs years after controversial approval
Sprout's female libido drug Addyi back in FDA's crosshairs years after controversial approval esagonowsky Wed, 07/14/2021 - 11:34
Vectura’s $1.45B sale to tobacco giant Philip Morris under fire from British business secretary: report
Vectura's $1.45B sale to tobacco giant Philip Morris under fire from British business secretary: report fkansteiner Wed, 07/14/2021 - 11:30
Merck looks to overturn FDA’s Keytruda rebuff with updated triple-negative breast cancer data
Merck looks to overturn FDA's Keytruda rebuff with updated triple-negative breast cancer data aliu Wed, 07/14/2021 - 10:35
Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil’s Hypera for $190M
Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil's Hypera for $190M kdunleavy Wed, 07/14/2021 - 10:20
Klick Health video riffs on a Beatles song to encourage people to ‘Get Vaxxed’
Klick Health video riffs on a Beatles song to encourage people to 'Get Vaxxed' bbulik Wed, 07/14/2021 - 09:57
Congress has a ‘time-limited window’ to shake up drug pricing, employers, health groups say
Congress has a 'time-limited window' to shake up drug pricing, employers, health groups say fkansteiner Wed, 07/14/2021 - 09:35
That $56,000 price on Biogen’s Aduhelm? It doesn’t factor waste that could total $2B annually: expert
That $56,000 price on Biogen's Aduhelm? It doesn't factor waste that could total $2B annually: expert kdunleavy Wed, 07/14/2021 - 07:40
AstraZeneca clears final antitrust hurdle as $39B Alexion buy wins U.K. nod
AstraZeneca clears final antitrust hurdle as $39B Alexion buy wins U.K. nod aliu Wed, 07/14/2021 - 06:07
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site nhigginsdunn Tue, 07/13/2021 - 16:50
So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds
So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds bbulik Tue, 07/13/2021 - 16:15
So far, not so good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds
So far, not so good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds bbulik Tue, 07/13/2021 - 16:15
All aboard the Cell Shuttle: Cellares’ cell therapy factory-in-a-box project attracts a 3rd partner in Poseida
All aboard the Cell Shuttle: Cellares' cell therapy factory-in-a-box project attracts a 3rd partner in Poseida fkansteiner Tue, 07/13/2021 - 14:54
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs fkansteiner Tue, 07/13/2021 - 11:36
Florida judge rules for generic, over-the-counter manufacturers of Zantac knockoffs, backing preemption claim
Florida judge rules for generic, over-the-counter manufacturers of Zantac knockoffs, backing preemption claim kdunleavy Tue, 07/13/2021 - 11:25